6 Trends In Global Antitrust M&A, And How General Counsel Can Deal With Them

Today, companies looking to merge with others across jurisdictions would do well to consider antitrust issues at the beginning of the transaction process; regulatory antitrust challenges to M&A are increasing globally. On Corporate Counsel, McDermott partners Jon B. Dubrow and Joel R. Grosberg discuss six risks to deals from antitrust regulators, such as vertical merger enforcement changes at the US DOJ, and ways to manage them.

Access the full article.

6 Trends In Global Antitrust M&A, And How General Counsel Can […]

By | October 22nd, 2019 ||

M&A Litigation And Commercial Disputes

Acquisitions in the life sciences industry very often involve developing and not-fully proven pharmaceutical products and medical devices. In such situations, the acquisition agreement often seeks to bridge a valuation gap by incorporating milestone, or earn-out, provisions, typically coupled with an obligation on the buyer to use “commercially reasonable efforts,” or something similar. Those clauses, and “material adverse effect” provisions, are frequently the source of litigation.

During this webinar, our attorneys addressed recent litigation regarding […]

By | October 12th, 2019 ||

New Fulsome M&A Checklist For 2019

Attached is a new, much more fulsome compendium of useful checklists for M&A matters for 2019!  Checklist M&A (2019)

By | October 6th, 2019 ||